• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Research Data
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.
 

Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.

Options
  • Details
  • Files
BORIS DOI
10.48350/160193
Publisher DOI
10.1016/j.jhep.2021.07.020
PubMed ID
34333101
Description
BACKGROUND & AIMS

Portal vein thrombosis (PVT) is a relatively frequent event in patients with cirrhosis. While different risk factors for PVT have been reported, such as decreased portal blood flow velocity (PBFV) and parameters related with severity of portal hypertension, these are based on retrospective studies assessing only a discrete number of parameters. The aim of the current study was to evaluate the incidence and risks factors for non-tumoral PVT development in a large prospective cohort of patients with cirrhosis.

METHODS

We performed an exhaustive evaluation of clinical, biochemical, inflammatory and acquired/hereditary hemostatic profiles in 369 patients with cirrhosis without PVT who were prospectively followed-up. Doppler ultrasound was performed at baseline and every 6 months or whenever clinically indicated. PVT development was always confirmed by computed tomography.

RESULTS

Twenty-nine patients developed non-tumoral PVT, with an incidence of 1.6%, 6% and 8.4% at 1, 3 and 5 years, respectively. Low platelet count, PBFV <15 cm/sec and history of variceal bleeding were factors independently associated with a high PVT risk. No relationship between PVT development and any other clinical biochemical, inflammatory and acquired or hereditary hemostatic parameter was found.

CONCLUSIONS

In patients with cirrhosis, the factors predictive of PVT development were mainly those related to the severity of portal hypertension. Our results do not support the role of hemostatic alterations (inherited or acquired) and inflammatory markers in the prediction of PVT in patients with cirrhosis.

LAY SUMMARY

Patients with cirrhosis and more severe portal hypertension are at higher risk of non-tumoral portal vein thrombosis development. Acquired or inherited hemostatic disorders, as well as inflammatory status, do not seem to predict the development of portal vein thrombosis in patients with cirrhosis.
Date of Publication
2021-12
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
Cirrhosis portal hypertension portal vein thrombosis
Language(s)
en
Contributor(s)
Turon, Fanny
Driever, Ellen G
Baiges, Anna
Cerda, Eira
García-Criado, Ángeles
Gilabert, Rosa
Bru, Concepció
Berzigotti, Annalisaorcid-logo
Universitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
Nuñez, Isabel
Orts, Lara
Reverter, Juan Carlos
Magaz, Marta
Camprecios, Genis
Olivas, Pol
Betancourt-Sanchez, Fabian
Perez-Campuzano, Valeria
Blasi, Annabel
Seijo, Susana
Reverter, Enric
Bosch Genover, Jaime
Universitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
Borràs, Roger
Hernandez-Gea, Virginia
Lisman, Ton
Garcia-Pagan, Juan Carlos
Additional Credits
Universitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
Series
Journal of hepatology
Publisher
Elsevier
ISSN
1600-0641
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: ae9592 [15.12. 16:43]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo